Sparc Binding Scfvs

Abraxis Bioscience, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/US2009/067032, filed Dec 7, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 9,295,733	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Term ends Dec 7, 2029 · High confidence	Abraxis Bioscience, LLC	In force	Term ends Dec 7, 2029	Term ends Dec 7, 2029	High confidence
US 10,053,504	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Term ends Dec 7, 2029 · High confidence	Abraxis Bioscience, LLC	In force	Term ends Dec 7, 2029	Term ends Dec 7, 2029	High confidence
US 9,308,279	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Term ends Feb 1, 2030 · High confidence	Abraxis Bioscience, LLC	In force	Term ends Feb 1, 2030	Term ends Feb 1, 2030	High confidence
US 9,314,537	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Term ends Feb 8, 2030 · High confidence	Abraxis Bioscience, LLC	In force	Term ends Feb 8, 2030	Term ends Feb 8, 2030	High confidence
US 8,809,507	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Term ends Dec 12, 2030 · High confidence	Abraxis Bioscience, LLC	In force	Term ends Dec 12, 2030	Term ends Dec 12, 2030	High confidence

5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.